White Paper

The Medicines Of Tomorrow: A Primer On The Gene Editing Landscape

Source: ElevateBio

By Adrian Oliver, Ph.D., Senior Scientist of Technology Development, Life Edit Therapeutics

GettyImages-877873518 cell and gene future

CRISPR gene editing offers the potential to permanently treat genetic diseases with just a single dose of medicine. This concept of “one and done” has revolutionized not only how we think about treating disease; it has also revolutionized how therapies for many diseases are now being discovered and developed.

While many people understand the potential of CRISPR technology to treat genetic diseases with previously unmet medical needs – it targets the mutated segment of DNA within the disease-related gene to “correct” it – many are still keen to understand how this novel technology works, which diseases it can and cannot treat, and the future opportunities enabled by this modality.

Learn more about the distinction between gene therapy and gene editing as well as the therapeutic potential of CRISPR treatments and the challenges that remain on the path toward clinical trials and eventual commercialization.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online